跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,306 条关于
“complement-mediated disorders”
全部
40,306
临床试验
33,592
药物
428
机构
97
资讯
6,189
去年
Ruxoprubart Shows Promising Phase II Results as Novel Monotherapy for Paroxysmal Nocturnal Hemoglobinuria
去年
Ruxoprubart Achieves Primary Endpoints in Phase 2 Trial for Paroxysmal Nocturnal Hemoglobinuria
去年
Novartis' FABHALTA Poised to Transform Treatment Landscape for Multiple Complement-Mediated Diseases
去年
Regeneron's Pozelimab and Cemdisiran Combo Shows Superior Hemolysis Control in PNH Patients
去年
CDSCO Approves Novartis' Protocol Amendment for Iptacopan Study in Rare Kidney Disorders
2个月前
Eculizumab-Induced Acute Heart Failure Decompensation: A Novel Cardiotoxic Signal in Complement-Mediated TMA
去年
CANbridge Pharmaceuticals Secures $12.7M Strategic Investment from Baheal Medical to Accelerate Rare Disease Drug Commercialization
去年
Roche's PiaSky Becomes First Subcutaneous PNH Therapy Approved in EU
上个月
Akebia Doses First Patient in Phase 2 Basket Trial of Ebribafusp for Rare Complement-Mediated Kidney Diseases
3天前
Akebia Doses First Patient in Phase 2 Basket Trial of Ebribafusp for Rare Complement-Mediated Kidney Diseases
第 1 页，共 619 页
上一页
下一页
